Because I3C triggers anti-proliferative signaling in 10AT-Her2 cells through a p53- dependent response, we examined whether cellular components that define the cancer stem/progenitor cell-like phenotype may be associated with the I3C regulation of the MDM2–p53 pathway. The gene discussed is ERBB2; the disease is cancer.